Clinical Trial Update: The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated the effect of corticotrophin-releasing hormone on esophageal motility in healthy volunteers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Motility Disorders

Drugs mentioned

• Corticotropin releasing hormone (CRH) (corticotropin releasing hormone)

Snippet

Sponsor: Prof Dr Jan Tack | Conditions: Esophageal Motility Disorders | Phase 4 | Status: COMPLETED